S8947-9800-9911-0016A Vitamin D Insufficiency in Determining Prognosis in Patients With Newly Diagnosed Follicular Lymphoma
RATIONALE: Studying samples of serum from patients with cancer in the laboratory may help doctors identify and learn more biomarkers related to cancer. It may also help doctors predict how well patients will respond to treatment.
PURPOSE: This research study is studying vitamin D insufficiency in determining prognosis in patients with newly diagnosed follicular lymphoma.
|Study Design:||Time Perspective: Retrospective|
|Official Title:||Vitamin D Insufficiency and Follicular Lymphoma Prognosis|
- Progression-free survival [ Time Frame: retrospective ]
- Objective response (confirmed and unconfirmed complete and partial responses) [ Time Frame: retrospective ]
|Study Start Date:||June 2010|
|Study Completion Date:||September 2011|
|Primary Completion Date:||September 2011 (Final data collection date for primary outcome measure)|
- To evaluate the role of pre-treatment serum 25(OH)D with regard to progression-free survival and objective response among patients with newly diagnosed follicular lymphoma, within the context of a uniformly treated and evaluated Phase III clinical trial in the modern therapeutic era.
OUTLINE: This is a multicenter study.
Pre-treatment serum samples are analyzed for 25(OH)D levels to determine vitamin D sufficiency or insufficiency.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01131221
|Principal Investigator:||Jonathan W. Friedberg, MD||James P. Wilmot Cancer Center|